MedPath
NMPA Approval

Deucravacitinib Tablets

国药准字HJ20230120

February 22, 2024

Drug Information

氘可来昔替尼片

颂狄多

片剂

6mg

化学药品

February 22, 2024

October 17, 2028

Company Information

Applicant Company

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Manufacturing Company

Patheon Inc

2100 SYNTEX COURT, MISSISSAUGA, ON, CANADA, L5N 7K9

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氘可来昔替尼片 - NMPA 批准文号 | MedPath